K. Kotani, S. Ichiba, M. Andou, et al., “Extracorporeal Membrane Oxygenation with Nafamostat Mesilate as an Anticoagulant for Massive Pulmonary Hemorrhage after Living-Donor Lobar Lung Transplantation,” The Journal of Thoracic and Cardiovascular Surgery, Vol. 124, No. 3, 2002, pp. 626-627. http://dx.doi.org/10.1067/mtc.2002.125638

has been cited by the following article:

• TITLE: Risk of Major Hemorrhage in Bilateral Lung Transplantation for Chronic Thromboembolic Pulmonary Hypertension: A Case Report*

  AUTHORS: Tomoyuki Nakagiri, Masato Minami, Masayoshi Inoue, Soichiro Funaki, Yasushi Shintani, Meinoshin Okumura

  KEYWORDS: Lung Transplantation; Chronic Thromboembolic Pulmonary Hypertension; Massive Bleeding; Control

  JOURNAL NAME: Open Journal of Organ Transplant Surgery, Vol.3 No.4, November 4, 2013

  ABSTRACT: Chronic thromboembolic pulmonary hypertension (CTEPH) is one of the indications for lung transplantation. When patients with CTEPH undergo transplantation, massive bleeding can occur because of severe pleural adhesions and collateral vessels that develop from the thoracic wall to the lungs. However, there has been no previous case report that has discussed the bleeding risk in detail. We report the case of a patient having CTEPH who underwent bilateral lung transplantation with massive blood loss (11,730 mL) in the first operation and required repeat operations for hemostasis. The patient underwent left upper lobectomy because compromised blood flew to the left upper lobe. He recovered from the operations by postoperative day 9; however, he died from pyothorax from an intractable air leak 56 days after transplantation.